Gland Pharma per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹68.51₹62.35₹42.40₹46.90₹47.44
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹68.47₹62.28₹42.40₹46.89₹47.43
₹628.67₹628.67₹555.40₹529.65₹483.23
₹408.19₹390.30₹340.89₹343.92₹220.07
—₹62.60₹55.52₹60.52₹22.10
₹32.59₹32.59₹31.60₹36.34₹8.55
—₹18.00₹20.00₹0.00₹0.00
16.516.516.516.516.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GLAND₹3,074.50

Gland Pharma Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABAUROPHARMAPPLPHARMASYNGENEWOCKPHARMAASTERDMCOHANCELALPATHLABMcap ₹50,655 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS47.4446.9042.4062.3568.51
Diluted EPS47.4346.8942.4062.2868.47
Book Value per Share483.23529.65555.40628.67628.67
Revenue per Share220.07343.92340.89390.30408.19
Cash Flow per Share22.1060.5255.5262.60—
Free Cash Flow per Share8.5536.3431.6032.5932.59
Dividends per Share0.000.0020.0018.00—
Shares Outstanding (cr)16.516.516.516.516.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.